Lion Point Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Hold |
45,900
| – | – | 8.62% | 3 |
|
|
2025
Q1 | $1.02M | Hold |
45,900
| – | – | 6.5% | 5 |
|
|
2024
Q4 | $908K | Sell |
45,900
-15,500
| -25% | -$307K | 4.75% | 8 |
|
|
2024
Q3 | $1.53M | Sell |
61,400
-43,291
| -41% | -$1.08M | 3.42% | 6 |
|
|
2024
Q2 | $1.95M | Sell |
104,691
-26,000
| -20% | -$485K | 3.56% | 6 |
|
|
2024
Q1 | $2.58M | Hold |
130,691
| – | – | 1.44% | 4 |
|
|
2023
Q4 | $2.29M | Hold |
130,691
| – | – | 1.15% | 7 |
|
|
2023
Q3 | $2.27M | Hold |
130,691
| – | – | 1.01% | 6 |
|
|
2023
Q2 | $1.84M | Buy |
130,691
+17,151
| +15% | +$241K | 0.83% | 9 |
|
|
2023
Q1 | $1.22M | Sell |
113,540
-232,960
| -67% | -$2.51M | 0.5% | 18 |
|
|
2022
Q4 | $3.69M | Sell |
346,500
-133,500
| -28% | -$1.42M | 0.53% | 13 |
|
|
2022
Q3 | $5.14M | Hold |
480,000
| – | – | 1.13% | 17 |
|
|
2022
Q2 | $5.14M | Hold |
480,000
| – | – | 0.59% | 21 |
|
|
2022
Q1 | $4.77M | Buy |
480,000
+425,000
| +773% | +$4.22M | 1.11% | 17 |
|
|
2021
Q4 | $647K | Sell |
55,000
-440,748
| -89% | -$5.18M | 0.17% | 23 |
|
|
2021
Q3 | $5.65M | Hold |
495,748
| – | – | 1.06% | 18 |
|
|
2021
Q2 | $6.91M | Hold |
495,748
| – | – | 1.19% | 16 |
|
|
2021
Q1 | $9.18M | Hold |
495,748
| – | – | 1.67% | 13 |
|
|
2020
Q4 | $8.76M | Hold |
495,748
| – | – | 1.69% | 13 |
|
|
2020
Q3 | $7.59M | Hold |
495,748
| – | – | 1.67% | 14 |
|
|
2020
Q2 | $12.6M | Hold |
495,748
| – | – | 3.06% | 13 |
|
|
2020
Q1 | $7.67M | Buy |
+495,748
| New | +$7.67M | 2.03% | 12 |
|